Meet Carmen Escalante, M.D.
Carmelita P. Escalante, M.D.
Department of General Internal Medicine, Division of Internal Medicine
About Dr. Escalante
I enjoy teaching and mentoring others. In addition, part of the role as Department Chair, is mentoring faculty. I have routinely lectured to various groups on internal medicine topics in cancer patients. I have regularly participated as a preceptor in the University of Texas Health Science Center sophomore medical student course, Introduction to Clinical Medicine. I have also annually participated as a faculty mentor for high school or college students in our institutional Summer Research Program and the statewide sponsored Internal Medicine Summer Preceptorship for medical students. In addition, we also regularly host medical observers that rotate through our department, and I have had significant interactions and teaching through this program. Most recently our division has initiated a program with Texas A&M and a number of their senior medical students have selected electives through our department and spent time with our faculty and me during the past year. Because of our success, we now have junior medical students from Texas A&M rotating with our faculty as part of their medicine core curriculum. We also have physician assistant students rotating with our faculty as part of their training program.
We also have a GIM fellowship program. Four fellows completed the program. This is a clinical research fellowship structured to develop and refine clinical research skills following internal medicine training. Each fellow has a clinical research project that is ongoing and led primarily by them with faculty supervision. One of the fellows worked with me and led a VTE clinical project. I plan to continue our educational endeavors and expect the department’s educational activities will continue to expand.
Present Title & Affiliation
Dual/Joint/Adjunct Appointment
Professor, Department of Health Science Center, Texas A&M Health Science Center College of Medicine, Bryan, College Station, TX
Professor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Department of Internal Medicine, The University of Texas Health Science Center, Houston, TX
Research Interests
Ongoing Research Support
PA11-0980 - 2013-present. Cancer-Related Fatigue (CRF) Clinic Retrospective Study: Reporting on PRO Data Captured Via Tablet Computer. Principal Investigator.
The purpose of this study is to describe our current patients, the results of their clinical evaluations, and their CRF-related outcomes. Patients to be included in this study were seen at the CRF Clinic after the clinic began using a tablet computer (i.e., iPad) for patients to use in completing their standard clinical assessments.
ID00-372, 2003−present. McNeil Consumer & Specialty Pharmaceuticals. “ A Randomized, Double-Blind, Two-period, Placebo-Controlled Crossover Trial of Sustained Release Methyphenidate in the Treatment of Fatigue in Breast Cancer Patients ”. The goal of the study is to determine if Nuvigil decreases fatigue levels in chronic myeloid leukemia patients. Principal Investigator.
PA12-0557- Retrospective Study: Axitinib-Induced Hypertension in Cancer Patients . Principal Investigator.
The specific aims of the study : Aim 1: To evaluate the frequency coordinated with practice patterns of axitinib-induced HTN in cancer patients (time to need first anti-HTN agent, type and number of anti-HTN agents used and success of management of HTN during and following treatment with axitinib). Aim 2: To assess the frequency of TKI dose reduction, withdrawal and delay in treatment of the malignancy due to HTN, proteinuria and/or acute kidney injury (AKI). Aim 3: To determine the time course for resolution of TKI-induced HTN, proteinuria and/or AKI upon completion of axitinib treatment. Titration of the anti-HTN is frequently necessary once the blood pressure begins to normalize. Typically, patients may be on multiple anti-HTN agents and require reduction of these agents so hypotensive symptoms do not occur.Aim 4: To assess if the development of HTN is a predictor of the patients’ clinical outcome: complete remission, incomplete response or disease progression in patients with RCC undergoing treatment with axitinib.
RCR05-0763 A Cancer-related Fatigue Clinic: A Descriptive Survey. Principal Investigator.
2005-0936 Fatigue and Symptom Burden in Febrile Neutropenia. Principal Investigator.
2009-0026 A Prospective Study of Cancer Patients Diagnosed with Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans. Principal Investigator.
DR09-0012 Retrospective Chart Review Study: To Examine the Relationship Between Fatigue and Apathy in Patients Enrolled in the Cancer-related atigue Clinic. Principal Investigator.
Completed Research Support
2009-0683, 2009 − 2012. Cephalon, Inc. “Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia (CML) on Imatinib, Dasatinib and Nilotinib," . Principal Investigator.
2008-0628, 2008−2011. Eisai, Inc. “Fragmin Treatment Study in Patients with Malignancies and Symptomatic Venous Thromboembolism”. The goal of the study is to determine if Concerta decreases fatigue levels in this patient population. Principal Investigator.
2010-0066, 2009-2011, UT MD Anderson Cancer Center.
“Collaborative Group Clinics for Cancer Survivors”.
The goal of this project was to develop and pilot test a novel method of healthcare delivery in women with chronic fatigue who have survived cancer.
Co-Principal Investigator
2006-0458, 2006-2010. Bristol-Myers Squibb. “A Randomized, Double-blind, Placebo-controlled Study of Apixaban for the Prevention of Thromboembolic Events in Patients Undergoing Treatment for Advanced Cancer: A Phase 2 Pilot Study”. The goal of this project was to determine if Apixaban helps prevent VTE in patients with advanced cancer. Principal Investigator.
2007-0232, 2007-2009. Sigma Tau Research. “Double Blind, Randomized, Placebo-Controlled, Multi-Center Study to Determine the Safety and Efficacy of Oral Acetyl-L-Carnitine (ACL) Administration to Non-Anemic Potentially Curable Breast Cancer Subjects”. The goal of the study was to determine if ACL improves fatigue levels in cancer patients. Principal Investigator.
2004-0107, 6-2005 to 5-2006. Ladies Leukemia League. “Effect of Tight Control of Blood Glucose during Hyper-CVAD Chemotherapy for Acutr Lymphocytic Leukemia”. The goal of the study was to determine if tight control of blood glucose in hyper-CVAD chemotherapy in ALL decreases relapse and improves survival. Collaborator.
2006-0348, 2003 to 2004. SCIOS Inc. “The Use of Nesiritide in the Management of Acute Diastolic Heart Failure”. The goal of the study was to determine if Nesiritide improves diastolic heart failure. Collaborator.
4-2006 to 12-2006. NIOSH. “Determination of Antineoplastic Drug Exposure in Healthcare Workers”. The goal of the study was to determine if healthcare workers were exposed to significant amounts of antineoplastic drugs. Principal Investigator.
ID00-078, 6-2000 to 10-2004. Pharmacia & Upjohn Grant. “Outpatient Treatment of Deep Venous Thrombosis (DVT) using Subcutaneous Dalteparin (Fragmin) in Low Risk Cancer Patients”. The goal of the study was to determine if Fragmin is effective for treatment of DVT in low risk cancer patients. Principal Investigator.
2000 to 2003. Yamaha Corp. “Exploring the Use of Octaphonic Sound for Reducing Treatment – Related Distress in Cancer Therapy”. The goal of the study was to determine if the use of Octaphonic sound reduced distress in cancer patients on treatment. Co-Principal Investigator.
RCR01-196, 1-2002 to 12-2002. Ortho Biotech Grant. “Identification of Clinical factors Associated with Severe Fatigue in Cancer Patients Seeking Acute Care.” The goal of the study was to determine the clinical factors associated with severe cancer-related fatigue seeking care in the emergency center. Principal Investigator.
Education & Training
Postgraduate Training
| 2022-2023 | Leading Teams - Accelerate, Leadership, MD Anderson Leadership Institute/Harvard Business Publishing, Houston |
| 2021-2022 | Leading Teams & Others, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2019-2019 | CoachRice Leadership, Rice/Doerr Institute for New Leaders, Houston, Texas |
| 2003-2003 | Advanced Training in Health Care Delivery Improvement, Intermountain Health Care, Salt Lake City, Utah |
| 2002-2003 | Faculty Leadership Academy, Leadership, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 1986-1988 | Resident, The University of Texas Medical School at Houston, Houston, Texas |
| 1985-1986 | Intern, The University of Texas Medical School at Houston, Houston, Texas |
Experience & Service
Administrative Appointments/Responsibilities
Department Chair, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - Present
Other Appointments/Responsibilities
Management of Fatigue in Adult Survivors of Cancer: ASCO Guideline Update, ASCO, Houston, 2024 - Present
Clinical Hiring Panel-Alternate member, MD Anderson Cancer Center, Houston, TX, 2022 - Present
Fatigue in Cancer Survivors Guideline Committee, ASCO, 2021 - Present
Advisory Board Member, Roger Hadfield Ogden Honor's College, LSU, Baton Rouge, LA, 2016 - Present
Panel member - Cancer Related Fatigue, ASCO, Alexandria, VA, 2013 - Present
Panel Member - Cancer Related Fatigue, NCCN, Washington, PA, 2003 - Present
Institutional Committee Activities
Member, 2011 Survivorship Research Symposium Planning, 2010 - Present
Member, Cancer Survivorship Program Clinical Care Workgroup, 2007 - Present
Honors & Awards
| 2024 | Top Doctors for 2024, Castle Connolly |
| 2022 | Outstanding Study Group and Leader Award, MASCC |
| 2021 | Top 1% Provider, Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) |
| 2021 | Dr. Robert F. Gagel Lifetime Achievement award recipient, The University of Texas M D Anderson Cancer Center - DoIM |
| 2017 | President Recognition Faculty Excellence in Financial Stewardship, The University of Texas MD Anderson Cancer Center |
| 2015 | Top Doctor in Houston, TX, International Association of Internists |
| 2015 | Elizabeth & John Cox Award, The University of Texas MD Anderson Cancer Center |
| 2014 | Doctor of Excellence, Leaders In Healthcare Network |
| 2013 | GIMSPP Decade of Service Award, Texas Chapter of the ACP Medical Students |
| 2013 | Top Doctor in Houston, TX, International Association of Internists (IAI) |
| 2012 | Nominated for Best Boss Awards, MD Anderson Cancer Center |
| 2011 | Honorable Mention, NIOSH Alice Hamilton Award |
| 2011 | Voted one of 2011-2012 Best Doctors in America, US News and World Report |
| 2010 | Speaker 2010 Spring Commencement-86th, Nicholls State University |
| 2009 | Outstanding Alumna of Nicholls State University, Nicholls State University |
| 1998 | Fellow in the American College of Physicians, American College of Physicians |
| 1993 | Scholarship AAMC, Professional Development Seminar for Junior Women Faculty |
Selected Publications
Peer-Reviewed Articles
- Martinez Leal, I, Balachandran Pillai, A, Foreman, J, Siu, KW, Heredia, N, Escalante, CP, Manzullo, EF, Christie, AJ, Lacourt, TE, Razouki, ZA, Hwang, JP. A Qualitative Study of the Knowledge of Metabolic Syndrome, Attitudes about Lifestyle Modifications, and Preferences for Lifestyle Interventions among Patients with Cancer and Metabolic Syndrome. Cancers 16(18), 2024. e-Pub 2024. PMID: 39335119.
- Franco Vega MC, Ait Aiss M, George M, Day L, Mbadugha A, Owens K, Sweeney C, Chau S, Escalante C, Bodurka DC. Enhancing implementation of the I-PASS Handoff Tool Using a Provider Handoff Task Force at a Comprehensive Cancer Center. Jt Comm J Qual Patient Safety 50(8):560-568, 2024. PMID: 38584053.
- Ullah F, Song J, Rojas Hernandez CM, Kroll MH, Escalante CP, Toale KM. Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer Associated Venous Thromboembolism. Journal of Clinical Oncology 34(26):e1005–e1016, 2023. e-Pub 2023. PMID: 37310796.
- Martinez Leal I, Pillai AB, Foreman JT, Siu KW, Heredia NI, Escalante C, Manzullo EF, Christie AJ, Lacourt TE, Razouki ZA, Hwang JP. A Qualitative Study of Knowledge of Metabolic Syndrome, Attitudes about Lifestyle Modifications, and Preferences for Lifestyle Interventions among Patients with Cancer and Metabolic Syndrome. Res Sq, 2023. e-Pub 2023. PMID: 37720029.
- Bade BC, Faiz SA, Ha DM, Tan M, Barton-Burke M, Cheville AL, Escalante CP, Gozal D, Granger CL, Presley CJ, Smith SM, Chamberlaine DM, Long JM, Malone DJ, Pirl WF, Robinson HL, Yasufuku K, Rivera MP. Cancer-Related Fatigue in Lung Cancer: A Research Agenda. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 207(5):e6-e28, 2023. e-Pub 2023. PMID: 36856560.
- Dickson K, Koom-Dadzie K, Brito-Dellan N, Escalante C. Risks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT): a narrative review. Support Care Cancer 30(10):8539-8545, 2022. e-Pub 2022. PMID: 35699781.
- Muñoz-Guglielmetti D, Cooksley T, Ahn S, Beato C, Aramberri M, Escalante C, Font C, Study Group MASCC. Risk stratification for clinical severity of pulmonary embolism in patients with cancer: a narrative review and MASCC clinical guidance for daily care. Support Care Cancer 30(10):8527-8538, 2022. e-Pub 2022. PMID: 35579753.
- Escalante CP. Introduction to practical aspects of cancer-associated thrombosis and related complications. Support Care Cancer 30(10):8487-8489, 2022. e-Pub 2022. PMID: 35779130.
- Font C, de Herreros MG, Tsoukalas N, Brito-Dellan N, Espósito F, Escalante C, Oo TH, Study Group MH. Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies. Support Care Cancer 30(10):8599-8609, 2022. e-Pub 2022. PMID: 35545722.
- Razouki ZA, Ali NT, Nguyen VQ, Escalante CP. Risk Factors Associated with Venous Thromboembolism in Breast Cancer: A Narrative Review. Support Care Cancer 30(10):8589-8597, 2022. e-Pub 2022. PMID: 35511300.
- Tsoukalas N, Brito-Dellan N, Font C, Butler T, Rojas-Hernandez CM, Butler T, Escalante C, Study Group MH. Complexity and clinical significance of drug-drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT). Support Care Cancer 30(10):8559-8573, 2022. e-Pub 2022. PMID: 35932318.
- Ladwa R, Pinkham EP, Teleni L, Hanley B, Lock G, Nixon J, Agbejule OA, Crawford-Williams F, Jones L, Pinkham MB, Turner J, Yates P, McPhail SM, Aitken JF, Escalante CP, Hart NH, Chan RJ. Telehealth cancer-related fatigue clinic model for cancer survivors: a pilot randomized controlled trial protocol (the T-CRF trial). BMJ Open 12(5), 2022. e-Pub 2022. PMID: 35577469.
- Wu IHC, Balachandran DD, Faiz SA, Bashoura L, Escalante CP, Manzullo EF. Characteristics of Cancer-Related Fatigue and Concomitant Sleep Disturbance in Cancer Patients. Journal of Pain and Symptom Management 63(1):e1-e8, 2022. e-Pub 2021. PMID: 34348178.
- Font C, Cooksley T, Ahn S, Rapoport B, Escalante C. Emergency management of incidental pulmonary embolism (IPE). Emerg Cancer Care 1(1):7, 2022. e-Pub 2022. PMID: 35844667.
- O'Connell C, Escalante CP, Goldhaber SZ, McBane R, Connors JM, Raskob GE. Treatment of Cancer - Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats. Oncologist 26(1):e8-e16, 2021. e-Pub 2021. PMID: 33275319.
- Cooksley T, Font C, Scotte F, Escalante C, Johnson L, Anderson R, Rapoport B. Emerging Challenges in the Evaluation of Fever in Cancer Patients at Risk of Febrile Neutropenia in the Era of COVID 19: A MASCC position paper. Supportive Care in Cancer 29(2):1129-1138, 2020. e-Pub 2020. PMID: 33230644.
- Rojas-Hernandez CM, Tang VK, Sanchez-Petitto G, Qiao W, Richardson M, Escalante C. Development of a Clinical Prediction Tool for Cancer Associated Venous Thromboembolism (CAT): The MD Anderson Cancer Center CAT model. Support Care Cancer 28(8):3755-3761, 2020. e-Pub 2020. PMID: 31828489.
- Agnelli G, Becattini C, Meyer G, Munoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M, Escalante C. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med (NEJM) 382(17):1599-1607, 2020. e-Pub 2020. PMID: 32223112.
- Abdelghani EH, Zerpa RG, Iliescu GD, Escalante CP. Schistosomiasis and Liver Disease: Learning from the Past to Understand the Present. Clinical Case Reports 8(8):1522 - 1526, 2020. e-Pub 2020. PMID: 32884787.
- Lacourt TE, Heijnen CJ, Manzullo EF, Escalante C. A Central Role for Apathy in the Effectiveness of Interventions for Cancer-Related Fatigue. Psycho Oncology 29(202010):1613-1619, 2020. e-Pub 2020. PMID: 32658377.
- Escalante CP, Chisolm S, Song J, Richardson M, Salkeld E, Aoki E, Garcia-Manero G. Fatigue, Symptom Burden and Health-Related Quality of Life in Patients with Myelodysplastic Syndrome, Aplastic Anemia, and Paroxysmal Nocturnal Hemoglobinuria. Cancer Med 8(2):543-553, 2019. e-Pub 2019. PMID: 30632713.
- Lacourt TE, Vichaya EG, Escalante C, Manzullo EF, Gunn B, Hess KR, Heijnen CJ, Dantzer R. An Effort Expenditure Perspective on Cancer-Related Fatigue. Psychoneuroendocrinology 96:109-117, 2018. e-Pub 2018. PMID: 29929087.
- Gonzalez CE, Brito-Dellan N, Banala SR, Rubio D, Aiss MA, Rice TW, Chen K, Bodurka DC, Escalante CP. Modified Tool Enabling Standardized Transitions of Care Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center. American Journal of Medical Quality 33(6). e-Pub 2018. PMID: 29779398.
- Gonzalez CE, Brito-Dellan N, Banala SR, Rubio D, Ait Aiss M, Rice TW, Chen K, Bodurka DC, Escalante CP. Handoff Tool Enabling Standardized Transitions between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center. Am J Med Qual:1062860618776096, 2018. e-Pub 2018. PMID: 29779398.
- Narayanan S, Escalante CP. Clinical Assessment of Cancer-Related Fatigue. Journal of Clinical Outcomes Management (JCOM) 24(5):217-227, 2017. e-Pub 2017.
- Mareedu N, Escalante C. Angiogenesis Inhibitor Induced Thromboembolism in Cancer Patients. Int J Cancer Clin Res 4(1), 2017. e-Pub 2017.
- Escalante CP, Gladish GW, Qiao W, Zalpour A, Assylbekova B, Gao S, Olejeme KA, Richardson MN, Suarez-Almazor ME. Prospective Cohort Study of Cancer Patients Diagnosed with Incidental Venous Thromboembolism on Routine Computed Tomography Scans. Support Care Cancer 25(5):1571-1577, 2017. e-Pub 2017. PMID: 28070669.
- Brito-Dellan N, Lam T, Richardson MN, Manzullo EF, Kallen MA, Yang D, Haas N, Escalante C. Utilizing Electronic Technologies to Measure Patient Reported Outcomes Assessment Completion Time in a Cancer-Related Fatigue Clinic at a Comprehensive Cancer Center. Journal of Clinical Oncology 34(26):69. e-Pub 2016.
- Escalante CP, Chang YC, Liao K, Rouleau T, Halm J, Bossi P, Bhadriraju S, Brito-Dellan N, Sahai S, Yusuf SW, Zalpour A, Elting LS. Meta-analysis of Cardiovascular Toxicity Risks in Cancer Patients on Selected Targeted Agents. Supportive Care in Cancer 24(9):4057-4074, 2016. e-Pub 2016. PMID: 27344327.
- Escalante CP, Lu M, Marten CA. Update of Targeted Therapy-Induced Hypertension: Basics for Non-Oncology Providers. Current Hypertension Reviews 12(2):112-120. e-Pub 2016. PMID: 26931476.
- Lu H, Champlin RE, Popat U, Pundole X, Escalante CP, Wang X, Qiao W, Murphy WA, Gagel RF. Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial. Bonekey Rep 5:843, 2016. e-Pub 2016. PMID: 28018583.
- Saligan LN, Olson K, Filler K, Larkin D, Cramp F, Yennurajalingam S, Escalante CP, del Giglio A, Kober KM, Kamath J, Palesh O, Mustian K, Working Group MAOSCICFS. Erratum to: The biology of cancer-related fatigue: a review of the literature. Support Care Cancer 23(9):2853, 2015. e-Pub 2015. PMID: 26081598.
- Yennurajalingam S, Reddy A, Tannir NM, Chisholm GB, Lee RT, Lopez G, Escalante CP, Manzullo EF, Frisbee Hume S, Williams JL, Cohen L, Bruera E. High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related Fatigue: A Preliminary Report. Integrative Cancer Theories 14(5):419-27, 2015. e-Pub 2015. PMID: 25873296.
- Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C. Cancer-Related Fatigue, Version 2, 2015. J Natl Compr Canc Netw 13(8):1012-39, 2015. e-Pub 2015. PMID: 26285247.
- Anand D, Escalante CP. Ongoing Screening and Treatment to Potentially Reduce Tyrosine Kinase Inhibitor-Related Fatigue in Renal Cell Carcinoma. J Pain Symptom Manage 50(1):108-17, 2015. e-Pub 2015. PMID: 25701692.
- Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, Schnipper HH, Lacchetti C, Ligibel JA, Lyman GH, Ogaily MS, Pirl WF, Jacobsen PB, Clinical Oncology ASO. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol 32(17):1840-50, 2014. e-Pub 2014. PMID: 24733803.
- Holmes HM, Nguyen HT, Nayak P, Oh JH, Escalante CP, Elting LS. Chronic Conditions and Health Status in Older Cancer Survivors. Eur J Intern Med 25(4):374-378, 2014. e-Pub 2014. PMID: 24389373.
- Escalante CP, Meyers C, Reuben JM, Wang X, Qiao W, Manzullo E, Alvarez RH, Morrow PK, Gonzalez-Angulo AM, Wang XS, Mendoza T, Liu W, Holmes H, Hwang J, Pisters K, Overman M, Cleeland C. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J 20(1):8-14, 2014. e-Pub 2014. PMID: 24445757.
- Elting LS, Chang YC, Parelkar P, Boers-Doets CB, Michelet M, Hita G, Rouleau T, Cooksley C, Halm J, Vithala M, Bossi P, Escalante C, Brennan MT, Oral Oncology MSGOTMAOSCICSO. Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: A meta-analysis. JSCC 21(11):3243-54, 2013. e-Pub 2013.
- Vu K, Busaidy N, Cabanillas ME, Konopleva M, Faderl S, Thomas DA, O'Brien S, Broglio K, Ensor J, Escalante CP, Andreeff M, Kantarjian H, Lavis V, Yeung SC. A Randomized Controlled Trial of an Intensive Insulin Regimen in Patients with Hyperglycemic Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 12(5):355-62, 2012. e-Pub 2012. PMID: 22658895.
- Levin M, Julian J, Liebman H, Escalante C, McCarty D. A Randomized Phase II Trial of Apixaban for the Prevention of Thromboembolism in Patients with Metastatic Cancer. Journal of Thrombosis and Haemostasias:1538-7836, 2012. e-Pub 2012.
- Zalpour A, Kroll M, Vahid AK, Syed WY, Escalante CP. Role of Factor Xa Inhibitors in Cancer-Associated Thrombosis: Any New Data?. Advances in Hematology(196135), 2011. e-Pub 2011.
- Escalante CP, Ali Z. Vascular Endothelial Growth Factor (VEGF) Inhibitor-Induced Hypertension: Basics for Primary Care Providers. Cardiology Research and Practice 11, 2011. e-Pub 2011. PMID: 21629798.
- Mortimer JE, Barsevick AM, Bennet CL, Berger AM, Cleeland C, DeVader S, Escalante CP, Gilreath J, Hurria A, Mendoza T, Rugo HS. Studying Cancer-Related Fatigue: Report of the NCCN Scientific Research Committee. JNCCN 8(12):1331-1339, 2011. e-Pub 2011.
- Mcdiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C. Chromosome 5 and 7 Abnormalities in Oncology Personnel Handling Anticancer Drugs. Journal of General Internal Medicine 52(10), 2010. e-Pub 2010.
- Connor TH, DeBord DG, Pretty JR, Oliver MS, Roth TS, Lees PS, Jr KE, Rogers B, Escalante CP, Toennis CA, Clark JC, Johnson BC, McDiarmid MA. Evaluation of Antineoplastic Drug Exposure of Health Care Workers at Three University-based US Cancer Centers. J Occup Environ Med 10(52):1019-27, 2010. e-Pub 2010. PMID: 20881620.
- Hwang JP, Holmes HM, Kallen MA, Ensor J, Etchegaray J, Saab R, Arbucke RB, King KM, Escalante CP. Accuracy of Reporting Current Medications by Cancer Patients Presenting to an Emergency Center. Support Care Cancer, 2010. e-Pub 2010.
- Berger AM, Abernethy AP, Atkinson A, Am B, Breitbart WS, Cella D, Cimprich B, Cleeland CM, Eisenberger MA, Escalante CP, Jacobsen PB, Kaldor P, Ligibel JA, Murphy BA, O'Connor T, Pirl WF, Rodler E, Rugo HS, Thomas J, Wagner LI. Cancer-Related Fatigue. J Natl Compr Canc Netw 8(8):904-31, 2010. e-Pub 2010. PMID: 20870636.
- Escalante CP, Kallen MA, Valdres R, Morrow PK, Manzullo E. Outcomes of a Cancer-Related Fatigue Clinic in Comprehensive Cancer Center. Journal of Pain and Symptom Management 39(4):691-701, 2010. e-Pub 2010.
- Hwang JP, Patlan J, de Achaval S, Escalante CP. Survival in Cancer Patients after Out-of-Hospital Cardiac Arrest. Supportive Care in Cancer 18(1):51-55, 2010. e-Pub 2010.
- Escalante CP, Manzullo EF. Cancer-Related Fatigue: The Approach and Treatment. Journal of General Internal Medicine 24(2):412-416, 2009. e-Pub 2009.
- Escalante C, Row M, Manzullo E, Qiao W, Gao S, Yeung S. Fatigue in a Low-Risk Febrile Neutropenia Treated as Outpatients. Jnl Symptoms & Signs, 2009. e-Pub 2009.
- Escalante CP, Manzullo EF, Lam TP, Ensor JE, Valdres RU, Wang XS. Fatigue and its Risk Factors in Cancer Patients Who Seek Emergency Care. J Pain Symptom Manage 36(4):358-66, 2008. e-Pub 2008. PMID: 18411011.
- Jr HL, Escalante CP, Garrison O, Foldi BX, Ogungbade GO, Essient EJ, Ward D. Testicular Cancer Incidence Trends in the USA (1975-2004): Plateau or Shifting Racial Paradigm?. Public Health 122(9):862-872, 2008. e-Pub 2008.
- Elting LS, Lu C, Escalante CP, Giordano SH, Trent JC, Cooksley C, Avritscher EB, Shih YC, Ensor J, Bekele BN, Gralla RJ, Talcott JA, Rolston K. Outcomes and Cost of Outpatient or Inpatient Management of 712 Patients with Febrile Neutropenia. J Clin Oncol 26(4):606-11, 2008. e-Pub 2008. PMID: 18235119.
- Liu W, Vyas A, Escalante CP, Weiser MA, Wang J, Geraci JM. Results of General Internal Medicine Consultations for Diabetes Mellitus in 283 Cancer Patients. Am J Med Sci 9(5):276-9, 2007. e-Pub 2007. PMID: 17505168.
- Geraci JM, Tsang W, Valdres RV, Escalante CP. Progressive Disease in Patients with Cancer Presenting to an Emergency Room with Acute Symptoms Predicts Short-Term Mortality. Support Care Cancer 14(2):161-166, 2006. e-Pub 2006. PMID: 16572312.
- Geraci JM, Escalante CP, Freeman JL, Goodwin JS. Comorbid Disease and Cancer: The Need for More Relevant Conceptual Models in Health Services Research. J Clin Oncol 23(30):7399-404, 2005. e-Pub 2005. PMID: 16234509.
- Escalante CP, Weiser MA, Lam T, Ho V, Yeung SC. Hypertension in Cancer Patients Seeking Acute Care: An Opportunity to Intervene. Am J Med Sci 330(3):120-7, 2005. e-Pub 2005. PMID: 16174995.
- Weiser MA, Cabanillas M, Vu K, Tamm EP, Wallace MJ, Escalante CP, Bresalier RS. Diagnostic Evaluation of Patients with a High Suspicion of Malignancy: Comorbidities and Clinical Predictors of Cancer. Am J Med Sci 330(1):11-8, 2005. e-Pub 2005. PMID: 16020994.
- Kamana M, Escalante CP, Mullen CA, Frisbee-Hume S, Rolston KV. Bacterial Infections in Low-Risk, Febrile Neutropenic Patients. Cancer 104(2):422-6, 2005. e-Pub 2005. PMID: 15937905.
- Escalante CP, Weiser MA, Manzullo E, Benjamin R, Rivera E, Lam T, Ho V, Valdres R, Lee EL, Badrina N, Fernandez S, DeJesus Y, Rolston K. Outcomes of Treatment Pathways in Outpatient Treatment of Low-Risk Febrile Neutropenic Cancer Patients. Support Care Cancer 12(9):657-62, 2004. e-Pub 2004. PMID: 15185134.
- Elting LS, Escalante CP, Cooksley C, Avritscher EB, Kurtin D, Hamblin L, Khosla SG, Rivera E. Outcomes and Cost of Deep Venous Thrombosis Among Patients with Cancer. Arch Intern Med 164(15):1653-61, 2004. e-Pub 2004. PMID: 15302635.
- Avritscher EB, Cantor SB, Shih YC, Escalante CP, Rivera E, Elting LS. Cost-Minimization Analysis of Low-Molecular-Weight Heparin (Dalteparin) Compared to Unfractionated Heparin for Inpatient Treatment of Cancer Patients with Deep Venous Thrombosis. Support Care Cancer 12(7):531-6, 2004. e-Pub 2004. PMID: 14986076.
- Raad I, Hachem R, Hanna H, Afif C, Escalante CP, Kantarjian H, Rolston K. Prospective, Randomized Study Comparing Quinupristin-Dalfopristin to Linezolid in the Treatment of Vancomycin-Resistant Enterococcus Faecium Infections. J Antimicrob Chemother 53(4):646-9, 2004. e-Pub 2004. PMID: 14998986.
- Gao S, Escalante CP. Venous Thromboembolism and Malignancy. Expert Rev Anticancer Ther 4(2):303-20, 2004. e-Pub 2004. PMID: 15056060.
- Weiser MA, Cabanillas ME, Konopleva M, Thomas DA, Pierce SA, Escalante CP, Kantarjian HM, O'Brien SM. Relation Between the Duration of Remission and Hyperglycemia During Induction Chemotherapy for Acute Lymphocytic Leukemia with a Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone/methotrexate-cytarabine Regimen. Cancer 100(6):1179-85, 2004. e-Pub 2004. PMID: 15022284.
- Bruera E, Driver L, Barnes EA, Willey J, Loren S, Lynn Palmer J, Escalante CP. Patient-Controlled Methylphenidate for the Management of Fatigue in Patients with Advanced Cancer. J Clin Oncol Vol 21:4439-43, 2003. e-Pub 2003.
- Raad, II, Escalante CP, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey E, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KVI. Treatment of Febrile Neutropenic Cancer Patients Requiring Hospitalization: A Prospective, Randomized Study Comparing Imipenem and Cefepime. Cancer 98, 2003. e-Pub 2003.
- Escalante CP, Manzullo E, Valdres R. NCCN Cancer-Related Fatigue Panel Members and Writing Committee (Escalante C). Cancer-Related Fatigue Clinical Practice Guidelines in Oncology. JNCCN 1:308-31, 2003. e-Pub 2003.
- Escalante, Manzullo E, Valdres R. Cancer-Related Fatigue Clinic: Opportunities and Challenges. Journal of the National Comprehensive Cancer Network (JNCCN) 1(3):333-43, 2003. e-Pub 2003.
- Lee, A, Levine M, Baker R, Bowden C, Kakkar A, Prins M, Rickles F, Julian J, Math M, Haley S, Kovacs M, Escalante, Gent M. CLOT investigators (Escalante CP, CLOT investigator) Low Molecular-Weight Heparin versus a Coumadin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer. New England Journal of Medicine 349:146-158, 2003. e-Pub 2003.
- Manzullo E, Liu W, Escalante CP. Treatment of Cancer-Related Fatigue: An Update. Support Care Cancer 3(2):99-106, 2003. e-Pub 2003. PMID: 12560935.
- Escalante CP, Grover T, Johnson BA, Harle M, Guo H, Mendoza TR, Rivera E, Ho V, Lee EL, Cleeland CS. A Fatigue Clinic in a Comprehensive Cancer Center: Design and Experiences. Cancer 92(6):1708-13, 2001. e-Pub 2001. PMID: 11598891.
- Escalante CP, Martin CG, Elting LS, Price KJ, Manzullo EF, Weiser MA, Harle TS, Cantor SB, Rubenstein EB. Identifying Risk Factors for Imminent Death in Cancer Patients with Acute Dyspnea. J Pain Symptom Manage 20(5):318-25, 2000. e-Pub 2000. PMID: 11068153.
- Escalante CP, Kurtin D, Rivera E, Elting LS. Severity of Illness, Outcomes, and Resource use in Elderly Cancer Patients with Deep Venous Thrombosis. Clin Appl Thromb Hemost 6(3):175-8, 2000. e-Pub 2000. PMID: 10898279.
- Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberger MA, Escalante CP, Hinds P, Jacobsen PB, Kaldo P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C. NCCN Practice Guidelines for Cancer Related Fatigue. Oncology (Hunting) 14 (11A):151-61, 2000. e-Pub 2000.
- Weiser, MA, O'Brien S, Escalante CP, Manzullo E. Tuberculous Meningitis in a Patient with Acute Myelogenous Leukemia. Leukemia and Lymphoma 33:187-192, 1999. e-Pub 1999.
- Escalante CP, Manzullo EF, Weiser MA, Rubenstein EB. The Generalist Finds a Niche in a Comprehensive Cancer Center: A Decade of Growth at the University of Texas M.D. Anderson Cancer Center. Cancer Control 5(3):271-276, 1998. e-Pub 1998. PMID: 10761061.
- Escalante CP, Rubenstein EB, Rolston KV. Outpatient Antibiotic Therapy for Febrile Episodes in Low-risk Neutropenic Patients with Cancer. Cancer Invest 15(3):237-42, 1997. e-Pub 1997. PMID: 9171858.
- Escalante CP, Martin CG, Elting LS, Rubenstein EB. Medical Futility and Appropriate Medical Care in Patients Whose Death is Thought to be Imminent. Support Care Cancer 5(4):274-80, 1997. e-Pub 1997. PMID: 9257423.
- Martin CG, Kennedy KF, Elting LS, Manzullo E, Escalante CP, Rubenstein EB. Incidence of Emergency Visits among Oncology Patients Receiving Outpatient Chemotherapy: Implications for Care in a Capitated Market. Cancer Control 3(5):435-441, 1996. e-Pub 1996. PMID: 10764502.
- Escalante CP, Rubenstein EB, Rolston KV. Outpatient Antibiotic Treatment in Low-risk Febrile Neutropenic Cancer Patients. Support Care Cancer 4(5):358-63, 1996. e-Pub 1996. PMID: 8883229.
- Escalante CP, Martin CG, Elting LS, Cantor SB, Harle TS, Price KJ, Kish SK, Manzullo EF, Rubenstein EB. Dyspnea in Cancer Patients. Etiology, Resource Utilization, and Survival-implications in a Managed Care World. Cancer 78(6):1314-9, 1996. e-Pub 1996. PMID: 8826956.
- Rubenstein, EB, Rolston K, Benjamin RS, Loewy J, Escalante CP, Manzullo E, Hughes P, Moreland B, Fender A, Kennedy K, Holmes F, Elting L, Bodey GP. Outpatient Treatment of Febrile Episodes in Low-Risk Neutropenic Patients with Cancer. Cancer 71:3640-46, 1993. e-Pub 1993.
- Escalante CP. Management of Superior Vena Cava Syndrome. Oncology 7:61-68, 1993. e-Pub 1993.
- Rubenstein EB, Escalante CP. Hypertensive Crisis. Crit Care Clin 5(3):477-95, 1989. e-Pub 1989.
Invited Articles
- Manzullo EF, Escalante CP. Research into Fatigue. Hematol Oncol Clin North Am 16(3):619-628, 2002. e-Pub 2002. PMID: 12170571.
- Valdres, RU, Escalante C, Manzullo E. Fatigue: A Debilitating Symptom. Nursing Clinic North America Vol 36:785-94, 2001. e-Pub 2001.
- Escalante, Martin CG, Alexis U, Geraci J. Frequency in Physician Communications with Cancer Patients near End of Life. Journal of General Internal Medicine, Society of General Internal Medicine, San Diego, CA Vol 16:p. 129, 2001. e-Pub 2001.
- Manzullo, Escalante C, Weiser MA, Freedman R, Forman A. Case Report: An Elderly Woman with an Ovarian Mass and Myasthenia Gravis. Resident & Staff Physician Vol. 47, 2001. e-Pub 2001.
- Escalante CP. What Constitutes a Medical Emergency in Cancer Survivors?. Coping with Cancer Vol 13(No. 2):29-30, 1999. e-Pub 1999.
- Manzullo, E, Sneige N, Singletary SE, Escalante C. Diagnosis of a Breast Mass in a Young Woman. Primary Care & Cancer Vol 18(No. 9):15-21, 1998. e-Pub 1998.
- Escalante CP, Raad I, Gokaslan Z, Garcia R, Fuller G. Cerebellar Mass: Is it Malignancy or Histoplasmosis?. Primary Care & Cancer Vol 18(No. 10):35-40, 1998. e-Pub 1998.
- Weiser, MA, Frisbee-Hume S, Manzullo E, Escalante C, Rubenstein EB. Identification and Outpatient Management of the Low-Risk Febrile Neutropenic Patient with Cancer. Home HealthCare Consultant Vol. 3(No. 4):35-49, 1996. e-Pub 1996.
Manuals, Teaching Aids, Other Teaching Publications
- Narayanan S, Escalante C. Clinical Assessment and Management of Cancer-Related Fatigue. Coping Magazine, 2017.
- Helge T, Cassileth B, Escalante CP, Knobf T, Neyer K, O'Connor K. Guide to Understanding Insomnia and Fatigue. LBBC, 2009.
- Escalante CP. A Patient Guide for Managing Cancer-Related Fatigue. The University of Texas, M. D. Anderson Cancer Center, 2009.
- Mundy S, Manzullo E, Escalante C. Medical Backgrounder on Cancer-Related Fatigue. Timely Topics in Medicine, 2003.
- Escalante C. Treatment for Cancer-Related Fatigue: An Update. MASCC/ISOO 14th International Symposium, 2002.
Other Articles
- Laguna JC, Cooksley T, Ahn S, Tsoukalas N, Oo TH, Brito-Dellan N, Esposito F, Escalante C, Font C, Study Group MH Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care. Support Care Cancer 30(10):8577-8588, 2022. PMID: 35932317.
- Krishnan S, Sarda S, Kunzweiler C, Wu M, Sundaresan S, Huynh L, Duh MS, Escalante CP Literature Review of Fatigue Scales and Association with Clinically Meaningful Improvements in Outcomes among Patients with and without Paroxysmal Nocturnal Hemoglobinuria. Adv Ther 39(5):1959-1975, 2022. PMID: 35316499.
- Soones T, Ombres R, Escalante C An Update on Cancer-Related Fatigue in Older Adults: A Narrative Review. J Geriatr Oncol 13(2):125-131, 2022. PMID: 34353750.
- Ombres R, Escalante C Worn Down with Cancer Related Fatigue - We've Got the Answer You've Been Looking For. Coping Magazine(March/April Issue):57, 2021.
- Zerpa R, Abdelghani EH, Iliescu G, Escalante C Enormous hemangioma of the Liver. BMJ Case Rep 12(3), 2019. PMID: 30936329.
- Narayanan S, Escalante C Frequently Asked Questions about Cancer-Related Fatigue. Coping with Cancer, 2018.
- Saligan LN, Olson K, Filler K, Larkin D, Cramp F, Sriram Y, Escalante CP, del Giglio A, Kober KM, Kamath J, Palesh O, Mustian K, Working Group MAOSCICFSG The biology of cancer-related fatigue: A Review of the Literature. Support Care Cancer 23(8):2461-2478, 2015. PMID: 25975676.
- Escalante CP Feeling Worn Down by Cancer-Related Fatigue. Coping July/August 14:21, 2014.
- Escalante Tips for Managing Fatigue in Bone Marrow Failure Diseases. The MDS Connection(6):1-2, 2011.
- Escalante CP House call: Managing Disease-Related Fatigue. OncoLog 56(8):1-2.
- Escalante Cancer-Related Fatigue: Assessment and Treatment. Up To Date, 2010.
- Escalante CP Are You Tired of Cancer-Related Fatigue?. Coping July/August 10, 2010.
- Escalante Tobacco Use. Empresarios Magazine, 2007.
- Escalante Tobacco Use. Familia's Latinas, 2007.
- Escalante Patterns of Fatigue and Effect of Exercise in Breast Cancer Patients Receiving Chemotherapy. Clinical Oncology News, 2007.
- Escalante C Cancer-related: Assessment and Treatment. UpToDate, 2004.
- Mundy S, Manzullo E, Escalante C Cancer-Related Fatigue. Timely Topics in Medicine, 2003.
- Escalante CP The Fatigue Interview. Brochure, Cancer Related Fatigue. Support Care Cancer 3 No 1(2):99-106, 2003. PMID: 12560935.
- Escalante CP, Weiser MA, Finkel K Hyperphosphatemia Associated with Phosphorus-containing Lin a Patient with Chronic Renal Insufficiency. South Med J 90(2):240-2, 1997. PMID: 9042182.
Abstracts
- Escalante CP, Chisolm S, Song J, Richardson M, Salkeld E, Aoki E, Garcia-Manero G. Fatigue, Symptom Burden and Health-Related Quality of Life of Patients with Myelodysplastic Syndrome. Cancer Medicine 8(2):543-553. e-Pub 2019. PMID: 30632713.
- Gonzalez CE, Brito-Dellan N, Banala SR, Rubio D, Ait Aiss M, Rice TW, Chen K, Bodurka DC, Escalante CP. Modified tool enabling standard transitions of care between the Emergency Department and the hospitalist inpatient service at a major cancer center. Sage Journal, 2018. e-Pub 2018. PMID: 29779398.
- Escalante CP, Zalpour A, Song J, Richardson M, Halm J, Yusuf SW, Gao S. Adverse Events of Rivaroxaban Usage in Younger Versus Older Cancer Patients. Science Direct 164(Supplement 1):S220-S221. e-Pub 2018.
- Lacourt T, Escalante C, Manzullo E, Vichaya E, Cleeland C, Heijnen C, Danzter R. Deconstructing cancer-related fatigue: Increased effort expenditure as a component of fatigue. Fifth State of the Science Cancer Survivorship Research Symposium:39, 2017. e-Pub 2017.
- Tang V, Escalante C, Qiao W, Lam T, Richardson M, Rojas-Hernandez CM. Performance of Khorana Score Models in Predicting Occurrence of Incidental Venous Thromboembolism (VTE) in Cancer. Journal of Thrombosis and Haemostasias:1156, 2017. e-Pub 2017.
- Brito-Dellan N, Lam T, Richardson M, Manzullo E, Kallen M, Yang D, Haas N, Escalante C. Utilizing Electronic Technologies to Measure Pro Assessment Completion Time in Clinical Practice. Journal of Clinical Oncology 34(26), 2016. e-Pub 2016.
- Escalante CP, Zalpour A, Song J, Richardson M, Lam T, Halm J, Yusuf SW, Gao S. Practice Patterns and Outcomes of Rivaroxaban Usage in Patients with Cancer. J Clin Oncol 34(7S), 2016. e-Pub 2016.
- Banala S, Gonzalez CE, Brito-Dellan N, Rubio D, Ais Ait M, Rice T, Chen K, Bodurka DC, Escalante CP. Safer Transitions of Care at a Major Cancer Center: The Emergency Center to Hospitalist Experience. Journal of Clinical Oncology 34(7s), 2016. e-Pub 2016.
- Bodurka DC, Ait Aiss M, Phu HP, Day LR, AbrahamV, Chen K, Mejia R, Razvi S, Gonzalez CE, Brito-Dellan N, Banala S, Rubio D, Vaughan-Adams N, Ruiz DS, Tan JC, Levenback MF, Frumovitz BZ, Escalante CP. Improving Transitions of Care Through Implementation of Standardized Handoff at a Comprehensive Cancer Center. Journal of Clinical Oncology 34(7s), 2016. e-Pub 2016.
- Escalante CP, Elting L, Halm J, Zalpour A, Bossi P, Yusuf S, Brito-Dellan N, Sahai S, Bhadriraju S, Rouleau T, Chang Y. Meta-analysis: Risk of Congestive Heart Failure in Selected Targeted Agents. Journal of Clinical Oncology 33(29s), 2015. e-Pub 2015.
- Patlan J, Perdon M, Manzullo E, Escalante C. Role of a Cancer Diagnosis Clinic in an Internal Medicine Residency Program. MASCC 2015, 2015. e-Pub 2015.
- Balanchandran D, Escalante C, Faiz SA, Bashoura L, Fellman B, Lam T, Manzullo E. Sleep Disturbance Contributes to CRF in Cancer Patients with Active Disease. MASCC 2015, 2015. e-Pub 2015.
- Escalante CP, Elting LS, Chang YC, Rouleau T, Halm J, Bossi P, Bhadriraju S, Brito-Dellan N, Sahai S, Yusuf SW, Zalpour A, Study Group ESOTM. Meta-analysis: Hypertension in Selected Targeted Agents. MASCC 2015, 2015. e-Pub 2015.
- Escalante CP, Lahoti A, Song J, Lu M, Zalpour A, Abisaid Baker R, Richardson M, Mudireddy M, Overman M, George M, Durant JB. Bevacizumab-induced Hypertension, Proteinuria and Acute Kidney Injury in Cancer Patients. MASCC 2014, 2014. e-Pub 2014.
- Escalante CP, Lahoti A, Palla S, Lu Maggie, Overman M, George M, Abisaid Baker R, Palasamudram Shakar S, Durand JB. Practice Patterns of Bevacizumab-induced Hypertension in Cancer Patients. Journal of Clinical Oncology 31(Number 15). e-Pub 2013.
- Escalante CP, Gladish GW, Qiao W, Assylbekova B, Zalpour A, Gao S, Olejeme KA, Baker Abisaid R, Richardson M, Suarez ME. A Prospective Study of Cancer Patients Diagnosed with Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans. MASCC/ISOO 2012, 2012. e-Pub 2012.
- Escalante CP, Meyers C, Reuben JM, Wang X, Qiao MS, Manzullo E, Alvarez R, Morrow PK, Gonzalez-Angulo A, Wang XS, Mendoza T, Liu W, Holmes H, Hwang J, Pisters K, Overman M, Cleeland C. A Randomized, Double Blind, Placebo-Controlled Crossover Trial of a Sustained Release Methylphenidate in Cancer-Related Fatigue. ASCO 2012, 2012. e-Pub 2012.
- Escalante CP, Manzullo E, Rodriguez S, de Achaval S, Novy DM, Suarez ME. Collaborative Group Clinics (CGCs) for Cancer-Related Fatigue. CPRIT 2011, 2011. e-Pub 2011.
- Kallen M, Manzullo E, Lam T, Yang D, Escalante CP. The Effects of Pain and Other Symptoms on Cancer-Related Fatigue. CPRIT 2011, 2011. e-Pub 2011.
- Kallen M, Yang D, Manzullo E, Escalante CP. Using a Web-based System in a Clinical Setting to Assess Cancer-Related Fatigue. CPRIT 2011, 2011. e-Pub 2011.
- Hwang JP, Holmes HM, Kallen MA, Ensor J, Etchegaray J, Saab R, Arbuckle RB, King KM, Escalante CP. Accuracy of Reporting Current Medications by Cancer Patients Presenting to an Emergency Center. Supportive Care Cancer 18(10):1347-1354, 2010. e-Pub 2010.
- Olejeme K, Suarez-Almazor M, Gladish GW, Lei X, Escalante CP. Prevalence of Unsuspected Venous Thromboembolism on Routine Computed Tomography Scans in Cancer Patients. ASCO 2010, 2010. e-Pub 2010.
- Escalante CP, Kallen MA, Duffy J, Valdres R, Morrow PK, Manzullo E. Does Apathy Impact Cancer Patient Symptom Burden. ASCO 2010, 2010. e-Pub 2010.
- Escalante CP, Row M, Manzullo E, Qiao W, Gao S, Yeung SJ. Fatigue in Low-Risk Febrile Neutropenia (FN) Treated as Outpatients (OPs). The Journal of Supportive Oncology 7(5):195-196, 2009. e-Pub 2009.
- Escalante CP. Extended Treatment of Venous Thromboembolism in Patients with Cancer: An Analysis of Low-Molecular-Weight Heparin (LMWH) Randomized Clinical Trials. The Journal of Supportive Oncology 6(7):337-338, 2008. e-Pub 2008.
- Oh J, Mendoza T, Cleeland C, Valdres R, Manzullo E, Escalante CP. Fatigue in Testicular Cancer Survivors. Support Care Cancer 16(6):653, 2008. e-Pub 2008.
- Hwang J, Ensor J, Etchegaray J, Saab R, Arbuckle R, Escalante CP. Utilization of a Patient Medication Knowledge Tool: Implications for Medication Safety. Support Care Cancer 16(6):723-724, 2008. e-Pub 2008.
- Escalante CP, Kallen MA, Manzullo E, Valdres R, Lam T, Cleeland C. Too Tired to Recover? Outcomes of a Cancer-Related Fatigue (CRF) Clinic. MASCC/ISOO 2008 International Symposium 16(6):650-651, 2008. e-Pub 2008.
- Escalante. The Efficacy and Safety of Molecular-weight Heparins (LMWHs) Compared with Vitamin K Antagonists (VKAs) in the Treatment of Recurrent Venous Thromboembolism (VTE) in Patients with Cancer: An Analysis of Randomized Clinical Trials. ASCO 2008(9609), 2008. e-Pub 2008.
- Vu K, Strom S, Konopleva M, Thomas D, Faderl S, Gruschkus S, Hubbard J, Escalante C, Andreeff M, Kantarjian H, Lavis V. Prevalence of Hyperglycemia and Obesity in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia. Proc American Diabetes Association, 2007. e-Pub 2007.
- Cabanillas ME, Thomas DA, Hoff AO, Foudray MC, Mattiuzzi GN, Kantarjian HM, Escalante C, Gagel RF. Vitamin D Deficiency Occurs with High Frequency in Acute Leukemia. Journal of Bone and Mineral Research 96, 2005. e-Pub 2005.
- Manzullo E, Rolston K, Escalante. Mucositis: Predictors of Outpatient Failure in Febrile Neutropenia. Abstracts of the 15th International Symposium Supportive Care in Cancer, Berlin, Germany Vol. 11 No.6, 2003. e-Pub 2003.
- Escalante, Lam T, Valdres T, Geraci JM, Yang Y, Smith T, Badrina N, Horace P, Hwang J, McMahon L, Row M. Factors Related to Hospital Admission in Solid Tumor Patients in a Cancer Center Emergency Department. Journal of General Internal Medicine, Society of General Internal Medicine, Vancouver, British Columbia Vol 18, Sup 1:p. 223, 2003. e-Pub 2003.
- Escalante CP, Martin CG, Alexis U, Geraci J. Frequency in Physician Communications with Cancer Patients Near End of Life. 2nd Annual Kelsey Research Foundation, Houston Area Health Services & Outcomes Research Conference, 2001. e-Pub 2001.
- Geraci JM, Tsang W, Valdres R, Escalante CP. Outcomes of Emergency Room Presentation of Acutely Symptomatic Cancer Patients. 2nd Annual Kelsey Research Foundation, Houston Area Health Services & Outcomes Research Conference,:November 2001, 2001. e-Pub 2001.
- Escalante CP, Grover T, Johnson D, Harle M, Ho V, Rivera E, Cleeland C. Experiences of a Fatigue Clinic in a Comprehensive Cancer Center. Abstracts of the 12th International Symposium, Supportive Care in Cancer, Washington, DC Vol. 8 No.3, 2000. e-Pub 2000.
- Escalante, CP, Kurtin D, Rivera E, Elting LS. Severity of Illness, Outcomes, and Resource Utilization of Elderly Cancer Patients with Deep Venous Thrombosis. Abstract Book of the 10th International Symposium Supportive Care in Cancer, Nice, France, 1999. e-Pub 1999.
- Escalante CP, Weiser MA, Clayman GL, Rolston KVI, Alexanian R. Invasive Group A Streptococcal Infection. The Cancer Bulletin Vol. 47(No. 4):343-346, 1995. e-Pub 1995.
Book Chapters
- Ebede Chidinma C, Yongchang J, Escalante Carmen P. Cancer Related Fatigue in Cancer Survivorship. In: Care of Cancer Survivors. 6. Medical Clinics of North America, 1085-1097, 2017.
- Escalante CP, Manzullo EF. Fatigue. In: Advances in Cancer Survivorship Management. Springer, 361-373, 2015.
- Escalante CP, Manzullo EF, Weiss M. Oncologic Emergencies and Paraneoplastic Syndromes. In: In: Cancer Management: A Multidisciplinary Approach, 2014.
- Escalante CP, Manzullo EF, Weiss M. Oncologic Emergencies and Paraneoplastic Syndromes. In: In: Cancer Management: A Multidisciplinary Approach, 2013.
- Escalante CP, Yeung SCJ. Cardiac Emergencies in Cancer Patients. In: Cancer and the Heart. 2nd. People's Medical Publishing House-USA, 143-262, 2013.
- Escalante CP, Manzullo EF, Weiss M. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 15th. In: Cancer Management: A Multidisciplinary Approach, 2012.
- Escalante CP, Manzullo EF, Weiss M. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 13th. UBM Medica, 977-1002, 2011.
- Escalante CP, Manzullo E. Oncologic Emergencies and Paraneoplastic Syndrome. In: Cancer Management: A Multidisciplinary Approach. 14th. UBM Medica, 2011.
- Yeung SJ, Escalante CP. Oncologic Emergencies. In: In: Cancer Medicine. Chapter 142. 8th. BC Decker Inc, 2010.
- Escalante CP, Manzullo EF. Cancer-Related Fatigue. In: Manual of Psychosocial Oncology. Valentine/Duffy, 139-148, 2010.
- Escalante CP, Wang S. Cancer Related Fatigue. In: Medical Care of Cancer Patients. First Edition. People's Medical Publishing House, 53-59, 2009.
- Escalante CP, Manzullo E, Weiss M. Oncologic Emergencies and Paraneoplastic Syndrome. In: Cancer Management: A Multidisciplinary Approach. 12th. The Oncology Group CMP Medica, 943-966, 2009.
- Escalante CP, Manzullo E. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 12th, 2008.
- Escalante C, Valdres R. The Building of a Cancer-Related Fatigue Clinic. In: Ambulatory Nursing in the Oncology Setting. 2nd edition. Jones and Bartlett, p.413-421, 2007.
- Escalante CP, Manzullo E, Weiss M. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 11th edition. CPM Medica, 979 - 1002, 2007.
- Yeung SJ, Escalante CP. Cardiac Emergencies in the Cancer Patient. In: In: Cancer and the Heart. Chapter 17th, 2006.
- Yeung, SJ, Escalante C. Oncologic Emergencies. In: Cancer Medicine Vol 3. 7th edition. B.C. Decker Inc, 2246-2265, 2006.
- Yeung SJ, Escalante CP. Cardiac Emergencies in the Cancer Patients. In: Cancer and the Heart Chapter 17th. B.C. Decker Inc, 2006.
- Escalante C, Valdres R. The Building of a Cancer-Related Fatigue Clinic. In: Ambulatory Nursing in The Oncology Setting, 413-421, 2006.
- Escalante CP, Manzullo EF, Weiss M, Bonin SR. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 10th edition. The Oncology Group, 2006.
- Escalante CP, Manzullo EF, Weiss M, Bonin SR. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 9th edition. The Oncology Group, 979-1001, 2005.
- Escalante CP, Manzullo EF, Bonin SR. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 8th edition. The Oncology Group, 959-981, 2004.
- Young SJ, Escalante CP. Oncologic Emergencies in Cancer Medicine. In: Oncologic Emergencies Chapter 159. 6th. BC Decker Inc, 2003.
- Yeung, SJ, Escalante C. Orthopedic Oncologic Emergencies, Chapter 18th. In: Oncologic Emergencies. 6th edition. B.C. Decker Inc, P. 2659-80, 2003.
- Yeung SJ, Escalante CP. Oncologic Emergencies. In: In: Cancer Medicine. Chapter 159. BC Decker Inc, 2003.
- Escalante CP, Manzullo EF, Bonin SR, Gollamudi SV. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 7th edition. The Oncology Group, 941-965, 2003.
- Escalante C, Hwang J, Grover T, Rajagopal A, Deng G, Lazo-Diaz G, Forman A, Manzullo E, Gao S, Apisarnthanaraz N, Duvic M. Emergency Care at a Comprehensive Cancer Center. In: Oncologic Emergencies. 1st edition. B.C. Decker Inc, p. 1-5, 2002.
- Escalante, CP, Manzullo EF, Gollamudi SV, Bonin SR. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 6th edition. PRR, Inc, 889-912, 2002.
- Escalante CP, Hwang J, Grover T, Rajagopal A, Deng G, Lazo-Diaz G, Forman A, Manzullo E, Gao S, Apisarnthanarax N, Duvic M. Major Presenting Symptoms. In: Oncologic Emergencies. 1st edition. B.C. Decker Inc, p. 25-60, 2002.
- Escalante CP, Manzullo EF, Gollamudi SV, Bonin SR. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 5th edition. PRR, Inc, 835-859, 2001.
- Escalante CP, Gollamudi SV, Manzullo E, Bonin SR. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 4th edition. PRR, Inc, p.841-862, 2000.
- Reiger P, Escalante CP. Complications of Cancer Treatment. In: Primary Care Oncology. Saunders, p. 353-73, 1999.
- Escalante CP, Bonin SR, Manzullo E. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 3rd edition. PRR, Inc, 845-868, 1999.
- Escalante CP, Bonin SR, Manzullo EF. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 2nd edition. PRR Inc, p. 735-59, 1998.
- Komaki R, Escalante CP, Carrasco CH. Superior Vena Cava Syndrome. In: Tumor Board Case Management. Lippincott-Raven, 750-54, 1997.
- Escalante CP, Bonin SR. Oncologic Emergencies and Paraneoplastic Syndromes. In: Cancer Management: A Multidisciplinary Approach. 1st edition. PRR, Inc, 701-18, 1996.
- Escalante CP. Medical Care of the Cancer Patient Book Review. In: The Cancer Bulletin. 6. Rosenthal S, Carignan JR, Smith BD, p. 551, 1993.
- Rubenstein, EB, Escalante CP. Hypertensive Crisis. In: Cardiac Critical Care. In: Crit Care Clin. Vol 5, No.3. Saunders, p. 477-495, 1989.
Books (edited and written)
- Ed Manzullo EF, Gonzalez CE, Escalante CP, Yeung SJ. Oncologic Emergencies. Springer, 2016.
- Yeung SJ, Escalante CP, Gagel R. Medical Care of Cancer Patients. People's Medical Publishing House, 2009.
- Yeung SJ, Escalante CP. Oncologic Emergencies. B.C. Decker Inc, 2002.
Selected Presentations & Talks
Local Presentations
- 2022. CLL & Fatigue. Conference. Patient Power Webinar. Houston, TX, US.
- 2020. Human Body Systems & Cells. Conference. Human Body Systems & Cells, Project Based Learning Experience TEK 7.12. Houston, TX, US.
- 2019. Clinical Aspects of Cancer-Related Fatigue. Conference. Medical Oncology & Hematology 2019. Houston, TX, US.
- 2018. Practical Considerations When Choosing Anticoagulants in Cancer Patients. Conference. Bristol Myers Squibb Webinar. Houston, TX, US.
- 2017. Clinical Aspects of Cancer-Related Fatigue. Conference. myCancerConnection Survivorship Conference, Volunteer and Patient Programs. Houston, TX, US.
- 2017. Fatigue, Symptom Burden and Health-Related QoL of Patients with Myelodysplastic Syndrome, Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. Conference. GAP 2017 Onco-Medicine/Onco -Hospitalist. Houston, TX, US.
- 2017. Neutropenia: What you need to know. Conference. PIKNIK, My Cancer Connection. Houston, TX, US.
- 2017. Clinical Aspects of Cancer-Related Fatigue. Conference. Onco-Internal Medicine Symposium. Houston, TX, US.
- 2016. Clinical Aspects of Cancer Induced Fatigue, Diagnosis, Mechanisms, and Management of Cancer Treatment-Induced Neurotoxicity's. Conference. Department of Symptom Research Conference. Houston, TX, US.
- 2015. Cancer-Related Fatigue. Conference. Integrative Oncology Education Series, Department of General Oncology. Houston, TX, US.
- 2014. Bevacizumab-Induced Hypertension, Proteinuria, and Acute Kidney Injury in Cancer Patients. Conference. The Impact of Healthcare Reform on Quality of Care and Research. Houston, TX, US.
- 2014. Pitfalls in Cancer Diagnosis. Conference. 4th Annual Medical Oncology and Hematology 2014. Houston, TX, US.
- 2013. Living Well with MPNs, Coping with Fatigue. Conference. Patient Power. Houston, TX, US.
- 2013. Approach to Patients with Undiagnosed Cancer. Conference. Medical Oncology and Hematology 2013. Houston, TX, US.
- 2013. VEGF/TK Induced. Conference. 2nd Conference on Medical Issues in Cancer Patients & Survivors. Houston, TX, US.
- 2013. Cancer Survivorship, Cancer Survivorship Research. Conference. Cancer Survivorship Research Advisory Workgroup. Houston, TX, US.
- 2013. Hospitalist Program Expansion. Conference. Clinical Operations Forum. Houston, TX, US.
- 2012. The Latest in Hypertension Induced by VEGF/TK-Inhibitors. Conference. DoIM Grand Rounds. Houston, TX, US.
- 2012. Women in Science and Medicine at MD Anderson Cancer Center. Conference. Women in Science and Medicine at MD Anderson Cancer Center. Houston, TX, US.
- 2012. How to Maximize Your Effectiveness on Search Committees. Conference. Women Professors: Your Role. Houston, TX, US.
- 2011. Cancer Related Fatigue, Patient Affairs. Conference. Ovarian Support Group. Houston, TX, US.
- 2011. Cancer Related Fatigue: A Challenge for All. Conference. Cancer Survivorship for Health Care Professionals. Houston, TX, US.
- 2011. Fatigue, Too Tired to Recover?. Conference. Wellness Center - Picnic Session. Houston, TX, US.
- 2010. Career Girls Role Models. Conference. The Careers Project. Houston, TX, US.
- 2010. Fatigue and the Cancer Patient. Conference. Cancer Newsline Audio Podcast. Houston, TX, US.
- 2010. The State of Research in the Division of Internal Medicine. Conference. The University of Texas, MD Anderson Cancer Center. Houston, TX, US.
- 2010. Fatigue in Cancer Patients, Cancer Related Fatigue. Conference. UT Television Studio. Houston, TX, US.
- 2010. Advice for Career Success at M. D. Anderson. Conference. Career Success at M. D., Women Faculty Programs and Faculty Development. Houston, TX, US.
- 2010. If I Can Do It, You Can Do It. Conference. Women Faculty Programs (Keynote Speaker). Houston, TX, US.
- 2009. Venous Thromboembolism (VTE). Conference. The University of Texas, MD Anderson Cancer Center. Houston, TX, US.
- 2009. Too Tired to Recover?. Conference. Continuing Medical Education CME/Conference. Houston, TX, US.
- 2008. Mentoring. Conference. Mentoring Day for Faculty. Houston, TX, US.
- 2008. Fatigue and the Cancer Patient. Conference. Patient Power Webcast. Houston, TX, US.
- 2008. Cancer Related Fatigue - Current Management. Conference. Fatigue Week at MD Anderson. Houston, TX, US.
- 2008. Cancer-Related Fatigue: Current Status of Research and Management. Conference. Internal Medicine Grand Rounds. Houston, TX, US.
- 2008. Venous Thromboembolism. Conference. Venous Thromboembolism. Houston, TX, US.
- 2007. Venous Thromboembolism in Oncology. Conference. Lecture to personnel, EISAI. Houston, TX, US.
- 2007. Surviving the Aftermath of Cancer. Conference. DeBottis Memorial Lecture. Houston, TX, US.
- 2007. Venous Thromboembolism in Oncology. Conference. Venous Thromboembolism in Oncology. Houston, TX, US.
- 2007. Venous Thromboembolism in Oncology. Conference. Venous Thromboembolism in Oncology. Houston, TX, US.
- 2007. VTE Prevention and Treatment. Conference. Sarcoma Center Physician's Conference. Houston, TX, US.
- 2007. Venous Thromboembolism Prevention in Oncology. Invited. Bridging the Gaps to Improve Patient Outcomes. Houston, TX, US.
- 2006. What Every Women Needs to Know About Cancer. Conference. Annual Conference Hispanic Women in Leadership. Houston, TX, US.
- 2004. Management of Cancer-Related Fatigue: An Update. Invited. UT MD Anderson Cancer Center, Internal Medicine, and the Cancer Patient Conference. Houston, TX, US.
- 2003. The Clinical Challenge of DVT and PE in Special Patient Groups. Conference. The Clinical Challenge of DVT and PE in Special Patient Groups. Houston, TX, US.
- 2003. Emergency Care at a Comprehensive Cancer Center. Invited. UT MD Anderson Cancer Center, Oncologic Emergencies Conference. Houston, TX, US.
- 2002. Venous Thromboembolism: From Risk Assessment to Risk Management. Invited. Grand Rounds, Park Plaza Hospital. Houston, TX, US.
- 2001. Venous Thromboembolism: From Risk Assessment to Risk Management. Invited. Grand Rounds, Northwest Hermann Memorial Hospital. Houston, TX, US.
- 2001. Venous Thromboembolism: From Risk Assessment to Risk Management. Invited. Grand Rounds, Herman Memorial City Hospital. Houston, TX, US.
- 2000. DVT with LMWH. Conference. Treatment and Management of DVT with LMWH. Houston, TX, US.
- 2000. Living Fully with Cancer. Conference. Living Fully with Cancer. Houston, TX, US.
- 1999. Fatigue Awareness Week. Invited. Radio Interview. Houston, TX, US.
- 1999. Career in Medical Professions. Conference. 13th Annual Career and Education Day. Houston, TX, US.
- 1998. Careers in Medical Professions. Conference. Annual Career and Education Day. Houston, TX, US.
- 1997. Breast Cancer Awareness. Conference. Breast Cancer Awareness, Lecture. Houston, TX, US.
- 1997. Challenges Facing Minority Women. Conference. Minority Faculty Workshop. Houston, TX, US.
- 1997. 11th Annual Career and Education Day. Invited. 11th Annual Career and Education Day. Houston, TX, US.
- 1996. Cancer: Focus on Women's Health and Wellness. Invited. Recent Progress in Women's Health, First Annual Conference. Houston, TX, US.
- 1995. Overview of Risk Factors and Cancer. Conference. Overview of Risk Factors and Cancer. Houston, TX, US.
- 1994. Breast Cancer Awareness. Invited. Breast Cancer Awareness, Lecture to employees. Houston, TX, US.
- 1994. Breast Self-Examination and Early Detection. Invited. Breast Self-Examination and Early Detection., Lecture. Houston, TX, US.
- 1993. Nausea and Vomiting. Conference. Nausea and Vomiting, Lecture. Houston, TX, US.
- 1993. Neutropenic Fever. Conference. Neutropenic Fever, Lecture. Houston, TX, US.
- 1993. Fred G. Conrad Ambulatory Treatment Center. Conference. KHOU Radio Interview. Houston, TX, US.
- 1993. Health Awareness in Women: Breast and Cervical Cancer Screening. Invited. Health Awareness in Women: Breast and Cervical Cancer Screening. Houston, TX, US.
- 1993. BSE and Breast Cancer Prevention. Conference. Presentation for the Employees and Residents at Bellerive Senior Living. Houston, TX, US.
- 1993. Check It Out Program. Invited. Radio Interview. Houston, TX, US.
- 1993. Check It Out Program. Invited. Check It Out Program. Houston, TX, US.
- 1993. Graduation Address. Conference. Graduation Address. Houston, TX, US.
- 1991. Lipid Changes in the Treatment of Prostate Cancer. Conference. Hypertension Study Group. Houston, TX, US.
Regional Presentations
- 2021. The Internists Approach to the Cancer Patient - Selected Topics. Conference. The Internists Approach to the Cancer Patient, virtual, US.
- 2021. Cancer Related Fatigue. Conference. Patient Power Townhall, virtual, US.
- 2016. Aspects of Hypertension Management in Cancer Patients, Diagnosis Mechanisms, and Management of Cancer Treatment-Induced Neurotoxicity's. Conference. Neuropathy, Fatigue and Cognitive Impairment Conference. Clear Lake, TX, US.
- 2014. Fighting Fatigue in Cancer Survivors. Conference. Physician Community Educational Series, Quantia Inc, US.
- 2013. Role of PCP During Patient's Active Treatment for Cancer, Best Practices in CoManagement between Primary Care and Oncology. Conference, US.
- 2008. Provocative Issues and challenges for DVT Medical Decision Making in Oncology Patients. Conference. Improving DVT Prevention, Detection, and Treatment in High-Risk Specialties. Fort Worth, TX, US.
- 2002. Venous Thromboembolism: From Risk Assessment to Risk Management. Conference. Grand Rounds, Osteopathic Medical Center of Texas. Fort Worth, TX, US.
- 1994. Cancer Risks, Lecture to employees. Invited. Baytown, TX, US.
National Presentations
- 2023. Overview of Cancer Related Fatigue. Invited. Southern Sleep Society. Houston, TX, US.
- 2021. Adverse events of rivaroxaban usage in younger versus older cancer patients. Invited.
- 2021. Overview of Cancer-Related Fatigue. Invited.
- 2017. Fatigue, Symptom Burden, and Health-Related Quality of Life of Patients with Myelodysplastic Syndrome. Conference. MASCC Supportive Care in Cancer. Washington, DC, US.
- 2016. Practice Patterns and Outcomes of Rivaroxaban Usage in Patients with Cancer. Conference. Poster Presentation at 2016 Palliative Care in Oncology Symposium. San Francisco, CA, US.
- 2015. Meta-analysis: Risk of Congestive Heart Failure in Selected Targeted Agents. Conference. Poster ASCO Palliative Care 2015. Boston, MA, US.
- 2014. Fighting Fatigue in Cancer Survivors. Conference. Quantia Inc, US.
- 2014. Bevacizumab-Induced Hypertension, Proteinuria and Acute Kidney Injury in Cancer Patients. Conference. Oral presentation at MASCC 2014. Miami, FL, US.
- 2013. Update in Cancer-Related Fatigue. Invited. Aplastic Anemia & MDS International Foundation. Houston, TX, US.
- 2012. Update in Cancer-Related Fatigue. Invited. Aplastic Anemia & MDS International Foundation. Dallas, TX, US.
- 2012. A Prospective Study of Cancer Patients Diagnosed with Unsuspected Venous Thromboembolism (VTE) on Routine CT scans. Conference. Poster presentation at MASCC 2012. New York, NY, US.
- 2011. Diagnosis and Treatment of Oncologic Emergencies. Invited. MDACC Banner. Phoenix, AZ, US.
- 2011. Update on the Management of Cancer Pain and Cancer-Related Fatigue. Invited. Optum Health 2011 Oncology Conference. Orlando, FL, US.
- 2011. Managing Fatigue in Bone Marrow Failure Diseases. Invited. Phoenix, AZ, US.
- 2009. Fatigue in Low-Risk Febrile Neutropenia Treated as Outpatients. Conference. Poster presentation at the Supportive Oncology Conference. Chicago, IL, US.
- 2008. VTE Moderated Poster Session. Invited. Poster presentation at the Supportive Oncology Conference. Chicago, IL, US.
- 2008. Too Tired to Recover. Conference. Poster presentation MASCC. Houston, TX, US.
- 2008. The Efficacy and Safety of Low-molecular-weight Heparins (LMWHs) Compared with Vitamin K Antagonist (VKAs) in the Treatment of Recurrent Venous Thromboembolism (VTE) in Patients with Cancer: An Analysis of Randomized Clinical Trials. Invited. ASCO 44th Annual Meeting. Chicago, IL, US.
- 2003. Clinical Predictors of Severe Fatigue in a Cancer Center Emergency Center (EC). Conference. Poster Presentation American Society of Clinical Oncology. Chicago, IL, US.
- 2003. Up To Date: Cancer Related Fatigue Guidelines. Invited. National Comprehensive Cancer Network. Houston, TX, US.
- 2002. Treatment of Cancer-related Fatigue: An Update. Conference. 14th MASCC/ISOO Supportive Care in Cancer. Boston, MA, US.
- 2002. Outcomes in Outpatient Treatment of Low-Risk Febrile Neutropenic Cancer Patients. Conference. Poster Presentation American Society of Clinical Oncology. Orlando, FL, US.
- 2001. Frequency in Physician Communications with Cancer Patients Near End of Life. Conference. Poster Presentation, 2nd Annual Kelsey Research Foundation, Houston Area Health Services & Outcomes Research Conference. Houston, TX, US.
- 2001. Physician Communications in Patients Near End of Life. Conference. Poster Presentation, ASCO 37th Annual Meeting. San Francisco, CA, US.
- 2000. Cost of Dyspnea in Acutely Ill Cancer Patients with Imminent Death. Conference. Poster Presentation, 23rd Annual Meeting of the Society of General Internal Medicine. Boston, MA, US.
- 2000. Experiences of a Fatigue Clinic in a Comprehensive Cancer Center. Conference. Poster Presentation 12th International Symposium Supportive Care in Cancer. Washington, DC, US.
- 1999. Validation of a Model for Predicting Imminent Death in Acutely Ill Cancer Patients with Dyspnea. Conference. ASCO Poster Presentation. Atlanta, GA, US.
- 1996. Science & Research. Conference. Presentation for the Hispanic Career Day at the G. R. Brown Convention Center, Science & Research Section. Houston, TX, US.
- 1995. Predicting Imminent Death in Acutely Ill Cancer Patients with Dyspnea. Conference. Poster Presentation, 31st Annual Meeting of the American Society of Clinical Oncology. Los Angeles, CA, US.
- 1994. Breast Cancer Screening and Awareness. Invited. Breast Cancer Screening and Awareness, Series of community lectures. Elk City, OK, US.
- 1994. Resource Utilization and Surgical Outcomes in Elderly Cancer Patients. Conference. Poster Presentation, 17th Annual Meeting of the Society of General Internal Medicine. Washington, DC, US.
- 1994. Surgical Outcomes in Elderly Patients with Cancer. Conference. Poster Presentation, 6th International Symposium of Supportive Care. New Orleans, LA, US.
International Presentations
- 2024. Models of Care to Address Symptom Clusters Affecting CRF: Implementation Lessons for Low and Middle Resource Nations. Invited. Multinational Association of Supportive Care in Cancer (MASCC). Lille, FR.
- 2018. Challenge of Hemostasis in Cancer Patients. Invited. Multinational Association of Supportive Care in Cancer (MASCC). Vienna, AT.
- 2018. Adverse events of rivaroxaban usage in cancer patients. Invited. International Conference on Thrombosis & Hemostasis (ICTHIC). Bergamo, IT.
- 2018. Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients. Conference. International Conference on Thrombosis & Hemostasis (ICTHIC). Bergamo, IT.
- 2016. Adverse Events of Rivaroxaban usage in Cancer Patients. Conference. Multinational Association of Supportive Care in Cancer (MASCC). Adelaide, AU.
- 2014. Supportive and Comorbid Issues in Cancer Patients. Conference. Seoul, KR.
- 2010. Direct and Indirect Influences of Patient Apathy Disorder on Cancer-Related Fatigue. Conference. Poster presentation at MASCC 2010. Vancouver, CA.
- 2010. Sleep Disorders in Patients Should be Considered in Patients with Cancer-Related Fatigue. Conference. Poster presentation at MASCC 2010. Vancouver, CA.
- 2010. Fatigue in Low-Risk Febrile Neutropenia (FN) Treated as Outpatients (OPs). Conference. Poster presentation at MASCC 2010. Vancouver, CA.
- 2007. Venous Thromboembolism in Oncology. Invited. Hematology Oncology Conference. Cozumel, MX.
- 1999. Severity of Illness, Outcomes and Resource Utilization of Elderly Cancer Patients with Deep Venous Thrombosis. Conference. Poster Presentation, 10th International Symposium Supportive Care in Cancer. Nice, FR.
- 1996. Medical Futility and Appropriate Medical Care with Patients Whose Death is Predicted to be Imminent. Conference. Poster Presentation, 8th International Symposium Supportive Care in Cancer. Toronto, CA.
- 1995. Predicting Death in Lung Cancer Outpatients Presenting with Acute Dyspnea. Conference. Poster Presentation, 7th International Symposium Supportive Care in Cancer. Luxembourg, LU.
Formal Peers
- 2009. Legends and Legacies Book. Invited. Rice University, US.
- 2008. Venous Thromboembolism in Oncology. Invited. Scott & White, US.
- 2005. Identifying the Unmet Need: Risk Stratification in the Hospital Setting. Invited. Factor Xa Oncology Advisory Forum, US.
- 2005. Metabolic and Endocrine Emergencies in the Cancer Patient. Invited. Fairview Hospital Medical Grand Rounds, US.
- 2005. New Interventions in Bleeding, Thrombosis and Hematologic Malignancies. Invited. UD Markey Cancer Center, GB.
- 2005. Cancer-Associated Thrombosis: The Scope of its Impact. Invited. Regional Oncology Advisory Forum, US.
- 2003. Management of Cancer-Related Fatigue: An Update. Invited. Wayne State University School of Medicine, Cancer, US.
- 2003. Venous Thrombosis: A Problem in Supportive Care. Invited. Oncology National Board Meeting, US.
- 2003. Current Trends in Outpatient Cancer Care. Invited. Outpatient Care Institute, Outpatient Cancer Care:, US.
- 2002. Outpatient Cancer Care: What is New?. Invited. Outpatient Care Institute. The New Outpatient Rev, US.
- 2001. Deep Vein Thrombosis in Cancer Patients. Invited. 22nd Annual SWAHAP Medical Education Congress, US.
- 1999. Fatigue and Depression. Invited. Together in Hope: A Conference for Brain Tumor Pat, US.
- 1998. Outpatient Cancer Care: Transition from Inpatient to Outpatient Care. Invited. Outpatient Care Institute Conference, US.
- 1997. Outpatient Cancer Care: Transition from Inpatient to Outpatient Care. Invited. Outpatient Care Institute Conference, US.
- 1997. Oncologic Emergencies. Invited. II Congress Internacional AMEE-UNAM, MX.
- 1996. Oncologic Emergencies. Invited. First Fall CME Symposium Hendrick Medical Center, US.
- 1993. Breast Health. Invited. 1st Annual Health Care Awareness Seminar for Hispa, US.
- 1993. Breast Cancer Check It Out. Invited. Hispanic Women's Leadership Conference at the Double Tree, US.
- 1993. Prescription for Success. Invited. Houston Post, Viva Article, US.
Patient Reviews
CV information above last modified February 19, 2025
Photo Gallery
MD Anderson internal medicine physician Carmen Escalante with a patient
MD Anderson internal medicine physician Carmen Escalante, M.D.
Carmen Escalante, M.D.